van Lieshout M, West C E, Permaesih D, Wang Y, Xu X, van Breemen R B, Creemers A F, Verhoeven M A, Lugtenburg J
Division of Human Nutrition and Epidemiology, Wageningen University, Wageningen, Netherlands.
Am J Clin Nutr. 2001 May;73(5):949-58. doi: 10.1093/ajcn/73.5.949.
More information on the bioefficacy of carotenoids in foods ingested by humans is needed.
We aimed to measure the time required for isotopic enrichment of beta-carotene and retinol in serum to reach a plateau, the extent of conversion of beta-carotene dissolved in oil with use of beta-carotene and retinol specifically labeled with 10 (13)C atoms, and the intraindividual variation in response.
Indonesian children aged 8--11 y (n = 35) consumed 2 capsules/d, 7 d/wk, for < or =10 wk. Each capsule contained 80 microg [12,13,14,15,20,12',13',14',15',20'-(13)C(10)]beta-carotene and 80 microg [8,9,10,11,12,13,14,15,19,20-(13)C(10)]retinyl palmitate. Three blood samples were drawn per child over a period of < or =10 wk. HPLC coupled with atmospheric pressure chemical ionization liquid chromatography-mass spectrometry was used to measure the isotopic enrichment in serum of retinol with [(13)C(5)]retinol and [(13)C(10)]retinol and of beta-carotene with [(13)C(10)]beta-carotene. The beta-carotene in the capsules used had a cis-trans ratio of 3:1.
Plateau isotopic enrichment was reached by day 21. The amount of beta-carotene in oil required to form 1 microg retinol was 2.4 microg (95% CI: 2.1, 2.7). The amount of all-trans-beta-carotene required to form 1 microg retinol may be lower.
The efficiency of conversion of this beta-carotene in oil was 27% better than that estimated previously (1.0 microg retinol from 3.3 microg beta-carotene with an unknown cis-trans ratio). The method described can be extended to measure the bioefficacy of carotenoids in foods with high precision, requiring fewer subjects than other methods.
需要更多关于人类摄入食物中类胡萝卜素生物功效的信息。
我们旨在测量血清中β-胡萝卜素和视黄醇同位素富集达到平台期所需的时间、使用用10个(13)C原子特异性标记的β-胡萝卜素和视黄醇时溶解在油中的β-胡萝卜素的转化程度,以及个体内反应差异。
8至11岁的印度尼西亚儿童(n = 35)每天服用2粒胶囊,每周7天,持续≤10周。每粒胶囊含有80微克[12,13,14,15,20,12',13',14',15',20'-(13)C(10)]β-胡萝卜素和80微克[8,9,10,11,12,13,14,15,19,20-(13)C(10)]视黄醇棕榈酸酯。在≤10周的时间内,每个儿童采集三份血样。采用高效液相色谱结合大气压化学电离液相色谱-质谱法,用[(13)C(5)]视黄醇和[(13)C(10)]视黄醇测量血清中视黄醇的同位素富集,用[(13)C(10)]β-胡萝卜素测量血清中β-胡萝卜素的同位素富集。所用胶囊中的β-胡萝卜素顺反比为3:1。
在第21天达到平台期同位素富集。形成1微克视黄醇所需的油中β-胡萝卜素量为2.4微克(95%可信区间:2.1,2.7)。形成1微克视黄醇所需的全反式β-胡萝卜素量可能更低。
这种油中β-胡萝卜素的转化效率比先前估计的高27%(3.3微克β-胡萝卜素(顺反比未知)产生1.0微克视黄醇)。所描述的方法可扩展用于高精度测量食物中类胡萝卜素的生物功效,与其他方法相比所需受试者更少。